Skip to main content
. 2021 Feb 11;35(2):925–935. doi: 10.1111/jvim.16049

TABLE 4.

Physiologic and laboratory variables and their changes associated with 43 mTPE treatments in 17 dogs with immune‐mediated hematological disorders

Variable n (before/after) Before mTPE After mTPE P
HR (bpm) 42/42 82 (71‐110) 101 (73‐123) .12
Temperature (°C) 41/40 38.2 (37.9‐38.6) 38.2 (37.8‐38.4) .38
BW (kg) 37/37 16.6 (5.4‐31.3) 16.8 (5.6‐31.5) <.001*
ΔBW (kg) 37 0.200 (0.060‐0.600)
SBP (mmHg) 43/42 140 (128‐150) 140 (130‐157) .29
Hematocrit (L/L) 43/43 0.19 (0.16‐0.27) 0.22 (0.19‐0.25) .01*
Albumin (g/dL) 43/43 2.44 (2.22‐2.85) 2.29 (2.09‐2.45) <.001*
Urea (mg/dL) 43/43 17.9 (13.7‐23.6) 16.0 (13.5‐21.0) <.001*
Creatinine (mg/dL) 43/43 0.58 (0.42‐0.71) 0.58 (0.44‐0.71) .27
Bilirubin (mg/dL) 18/9 1.7 (0.6‐17.4) 11.1 (1.4‐34.3) .09
ΔBilirubin (mg/dL) 9

−4.2 (−8.8 to 0)

reduction: 15% (0 to 42)

CRP (mg/dL) 22/12 24.6 (8.7‐44.8) 7.4 (1.1‐12.3) .01*
pH 40/39 7.42 (7.40‐7.45) 7.39 (7.37‐7.42) .008*
Bicarbonate (mmol/L) 40/39 21.7 (20.0‐23.1) 21.7 (20.3‐23.3) .55

Note: Data are presented as median (IQR).

Abbreviations: BW, body weight; CRP, C‐reactive protein; HR, heart rate; SBP, systolic blood pressure.

*Indicates a statistically significant difference